Evaluation of crosslinked and non-crosslinked biologic prostheses for abdominal hernia repair by de Castro Brás, L. E. et al.
ORIGINAL ARTICLE
Evaluation of crosslinked and non-crosslinked biologic prostheses
for abdominal hernia repair
L. E. de Castro Bra ´s • S. Shurey • P. D. Sibbons
Received: 20 February 2011/Accepted: 1 July 2011/Published online: 31 July 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Introduction Abdominal wall defects and incisional her-
nias represent a challenging problem. Currently, several
commercially available biologic prostheses are used clini-
cally for hernia repair. We compared the performance and
efﬁcacy of two non-crosslinked meshes in ventral hernia
repair to two crosslinked prostheses in a rodent model.
Methods Animals were divided into 12 groups (4 matrix
types and 3 termination time-points per matrix). A ventral
defect was carefully created and overlapped with the bio-
logic prosthesis.
Results Major complications were seroma induction (3
mesh types), implant extrusion (1 mesh type), severe
inﬂammatory and immune responses (non-crosslinked
mesh), ﬁbrosis and mineralisation (3 mesh types). After
inﬂammation resolution, 3 of the matrices tested supported
hernia healing but with marked tissue and temporal dif-
ferences. AlloDerm
* and Surgisis Gold
TM showed tissue
reactivity with the host and a rapid rate of matrix remod-
elling. Bard CollaMend
TM* Implant proved to be inept for
hernia repair under the conditions tested. Permacol
TM
biological implant integration with host tissue increased
over time, supporting hernia healing with strength of tissue,
and appears to be a safe prosthetic material for ventral
hernia repair based on the results of this rodent study.
Keywords Hernia  Rat model  Acellular matrix 
Crosslinking  AlloDerm  CollaMend  Permacol 
Surgisis gold  SIS
Introduction
Abdominal wall defects caused by trauma, incisional her-
nias and tumour resection are a common and challenging
problem for surgeons. The risk of developing an incisional
hernia after a midline laparotomy is up to 11% [1]. The size
of the abdominal wall defect and the potential presence of
contamination of the site can complicate this commonly
performed surgical repair. Several methods are available
for abdominal wall defect repair. Primary closure is used
widely but in cases of large defects adequate tissue for
direct closure may not be available and most surgeons
agree that in such cases the defect should be repaired in a
tension-free manner using a prosthetic mesh material [2].
Several synthetic and biologically derived materials have
been used clinically to repair abdominal hernias. Non-
absorbable synthetic materials are commonly employed,
polypropylene mesh being the most used [3, 4]. Although
these meshes increase abdominal wall strength by
mechanical tension [5], mesh contraction and other serious
complications such as adhesions, ﬁstula formation, skin
erosion and increased susceptibility to infection can result
[6]. In addition, subsequent mesh extraction can be difﬁcult
due to dense tissue incorporation. Therefore, the use of
non-absorbable synthetic meshes in contaminated ﬁelds has
been strongly discouraged on the basis of high rates of
morbidity [7, 8]. Absorbable meshes have also been used
for abdominal hernia repair, including synthetic and natural
materials. Biological prostheses are derived from bovine,
porcine and human sources. These are typically collagen-
based and treated to remove cellular elements; some bio-
materials are crosslinked additionally to delay the degra-
dation of the collagen by collagenases [9].
The purpose of the study reported here was to compare
and evaluate Permacol
TM biological implant (Covidien,
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als, all commercially available and recommended for repair
of abdominal wall defects, in a rat model. Permacol
TM
biological implant is a dermal collagen porcine-derived
biomaterial. Fat deposits, hair follicles, sweat glands and
cells are removed during the manufacturer’s process,
deriving an acellular sheet of collagen and its constituent
elastic ﬁbres, with both proteins maintaining their original
three-dimensional (3D) structure [10]. To improve dura-
bility, Permacol
TM biological implant is stabilised chemi-
cally by crosslinking with hexamethylene diisocyanate
(HMDI) [11, 12]. Permacol
TM is a crosslinked biopros-
thesis currently in clinical use for hernia repair [13–16].
The study was designed to include both crosslinked and
non-crosslinked meshes. A literature research (Pubmed)
was performed to identify the bioprosthesis most commonly
used for abdominal wall repair. AlloDerm
* Regenerative
Tissue Matrix
TM (LifeCell, Branchburg, NJ) is an acellular
dermal matrix derived from donated human skin and clas-
siﬁed as banked human tissue. It is treated to remove both
the epidermis and cellular components while maintaining
an intact basement membrane and collagen. AlloDerm
*
has been commonly used for ventral hernia repair [17–20],
but several cases of post-surgical complications have been
reported [18, 21]. Surgisis Gold
TM (Cook Medical,
Bloomington, IN) is a porcine-derived small intestinal
submucosa (SIS) matrix that is processed to remove all
cells. The natural composition of SIS is retained and the
matrix is constituted by collagen, glycosaminoglycans,
proteoglycans and glycoproteins. Surgisis has been evalu-
ated extensively in animal models [22–24] and used clini-
cally in several surgical procedures, including abdominal
hernia repair [25–27]. At the time the study was designed,
from the crosslinked biomaterials commercially available,
Bard CollaMend
TM* Implant (Davol, Cranston, RI) showed
the features closest to Permacol
TM and therefore, to mini-
mize the variables evaluated (same biological source), was
chosen as the second crosslinked implant. CollaMend
TM*i s
a porous lyophilised acellular porcine dermal collagen
matrix. It is processed to remove all non-collagenous cel-
lular components and is crosslinked with 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC)
to increase strength and endurance. CollaMend
TM* is cur-
rently in clinical use for hernia repair [14, 28].
Materials and methods
Animals
This study was performed according to the regulatory
guidelines of the UK Home Ofﬁce. The Home Ofﬁce
Licence governing the studies directly speciﬁed the limits
of severity of effects on the animals.
Male Sprague–Dawley rats were purchased from Harlan
(Blackthorn, UK), allowed to acclimatise for at least
1 week prior to the beginning of the study, and were
monitored daily. They were fed a standard rat pellet-chow
diet (Special Diet Services, Witham, UK) and tap water
ad libitum throughout the study. Animals with weights
between 250 and 310 g were selected. Body weights were
recorded on the day of surgery and on the termination day.
Animals were distributed randomly within the 12 groups.
Materials
Dermal matrices were pre-treated according to the manu-
facturer’s instructions. The dermal materials were trimmed
aseptically into 5 9 2.5 cm implants. Pieces of non-
implanted material were ﬁxed in a 10% neutral buffered
formalin solution (NBF) solution for histological analysis.
Study design
Four treatment groups were constructed for each time
point. This resulted in a total of 81 animals for the com-
plete study (Table 1).
Surgical procedure
Rats were induced and maintained under general anaes-
thesia. A ventral midline incision was made from just
below the level of the rib cage, extending approximately
1.5 cm distally. Skin was elevated and retracted to allow
access to a site at the mid-lateral aspect of the caudal
peritoneal wall. Using a template, a 3 9 0.5 cm piece of
peritoneal wall was excised to leave the peritoneum intact
[29]. A piece of biomaterial was placed to cover and
overlap the excision equally at each aspect; the implants
were secured with absorbable sutures to the peritoneal wall
Table 1 Study groups and time point design
Study groups
Months 1 3 6
Group A1M C1M P1M SIS1M A3M C3M P3M SIS3M A6M C6M P6M SIS6M
Animals 6 9 6 6 6 9 6 6 6 9 6 6
Biomaterials: A AlloDerm
*, C Bard CollaMend
TM* Implant, P Permacol
TM biological implant, SIS Surgisis Gold
TM
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123and non-absorbable sutures were used to identify the cor-
ners of the implant. This procedure was performed only on
one side of the midline, in half the animals the other side
underwent creation of a ventral hernia defect without bio-
material implantation, and was therefore used as a control.
Necropsy
Animals were euthanased with an intra-peritoneal injection
of sodium pentobarbitone, and the operative sites were
identiﬁed and exposed. The complete operative site toge-
ther with adjacent tissue was removed; one-third (longitu-
dinally, approximately 4.2 cm
2) was resected to be used
fresh for integration strength testing by way of a tensi-
ometer and the remainder was ﬁxed in 10% NBF for his-
topathological analysis. From the opposite, control, side of
the animal, a similar-sized piece of peritoneal wall was
excised and ﬁxed.
Tensile strength
In studies where the implant integration with surrounding
tissue was tested mechanically, an In-Spec 2200 portable
tensiometer (Instron
, Bucks, UK) was used. Part of the
tissue outside the treatment area was sutured to the
movable end of the tensiometer, and the test material
sutured to the ﬁxed end of the tensiometer. The movable
section of the tensiometer moved away from the ﬁxed end
at a constant speed of 0.167 mm/s until dissociation
occurred either at the test material/tissue junction or in the
associated tissues or within the test material.
Histology
Fixed samples were processed to parafﬁn wax embedding
by routine automated procedures. Two 5 lm sections were
cut from each wax block in a transverse orientation, one
section was stained with haematoxylin and eosin (H&E)
and the other with picro sirius red F3B. H&E stain was used
for general assessment of the tissues and implant, and for
identiﬁcation of cellular type and tissue reaction. Picro
sirius red was used to enhance the natural birefringence of
collagen. Well conserved and physiologically normal col-
lagen shows bright birefringence using a polarised light
microscope whereas denatured or degraded collagen
appears black and non-birefringent. Sections were exam-
ined for implant presence, acute and chronic inﬂammation,
seroma, ﬁbrosis, giant cells, tissue integration, cellular
penetration, cellular density, neo-vascularisation, implant
structure retention and collagen degradation. Sections were
visualised using an Olympus BX40 microscope (Olympus
Optical, London, UK) with a CCD colour Olympus DP70
digital camera. Semi-quantitative analysis included
quantiﬁcation of inﬂammatory cells, neo-vascularisation
and cellular density (non-inﬂammatory host cells, mainly
ﬁbroblasts). A minimum of seven ﬁelds per slide were
counted at an objective magniﬁcation of 409. Fields were
randomly selected within the collagen implant itself and at
the interface between the implant and surrounding host
tissue. Implant-host tissue integration was measured by
analysis of the amount of actual tissue micro-interdigitation
(ﬁbroblasts, ﬁbrin, collagen) seen between the edges of the
implant and the immediately adjacent host tissue. Integra-
tion was measured and scored as a percentage of micro-
interdigitations observed per area of tissue interface; mea-
surements were performed with ImageJ software (Rasband,
ImageJ, US National Institutes of Health, Bethesda, MD).
The extent of cellular penetration was quantiﬁed (in per-
centage of the depth of the entire test sample) by measuring
minimal and maximal cell penetration per implant thickness
(in the same area); a minimum of six randomly selected
ﬁelds per slide were measured with DP controller software
(Olympus Optical), at an objective magniﬁcation of 109.
For descriptive purposes, a semi-quantitative histological
scoring criterion was generated (Table 2).
Statistical analysis
Histometric scores were analysed per matrix type and over
time using a two-way ANOVA to look for interaction
between mesh type and time-point. These tests were per-
formed in conjugation with Levene’s test to check for
homogeneity of variances; when variances were signiﬁ-
cantly different, two separate one-way variance analysis
were performed instead. One-way ANOVA was also used
to analyse the tensiometry results over time. When the
ANOVA (one-way and two-way) results were signiﬁcant, a
Bonferroni post hoc test was used to identify differences
within groups; when the variances were unequal, Tamh-
anes’s T2 post hoc test was used. P\0.05 was considered
as statistically signiﬁcant for all tests applied. Statistical
analysis was performed using SPSS Statistics 14.0 (SPSS,
Chicago, IL). Data was represented graphically using
GraphPad Prism
TM statistics software, version 4 (GraphPad
Software, La Jolla, CA).
Results
During the surgical procedure, CollaMend
TM* was found
to be an inﬂexible, stiff material that was difﬁcult to suture
into place. One animal from group C3M and one animal
from group C6M died post operatively due to anaesthetic
problems. All other animals recovered well from surgery.
Sixteen days post surgery, one animal from group C3M
had an open wound lateral to the middle incision caused by
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123friction between the implant and the skin; there was evi-
dence of implant extrusion and the animal had to be sac-
riﬁced. Since the implant was detached from the
surrounding tissues, tensiometry was not performed in this
sample. From 8, 14 and 28 days post implantation it was
noted that animals implanted with AlloDerm
*, Surgisis
Gold
TM (SIS) and CollaMend
TM* were developing sero-
mas. These animals were examined in detail and decisions
made as to their continuance in the study. Ten animals
from the AlloDerm
* groups showed evidence of seroma
(A1M n = 4, A3M n = 3 and A6M n = 3); all animals were
deemed acceptable for continuance in the study under an
increased observation regimen. Eight animals implanted
with SIS developed seroma, four animals had the seroma
drained and were kept in the study, while the other animals
had to be sacriﬁced due to the extent of the seroma (SIS1M
n = 2, SIS3M n = 1 and SIS6M n = 1). Six animals from
the CollaMend
TM* groups were noted to have partially
folded implants forming a ﬁrm protrusion. These implants
did not settle back into the original on-lay position and, as a
result, seroma developed between the implant and the
peritoneum. Eventually these animals chewed through the
skin overlying the implants and this meant the animals had
to be terminated prematurely (C1M n = 2, C3M n = 3 and
C6M n = 1).
Tensiometry
Tensiometry was used to study the resistance of the
implant/surrounding tissue complex to a constant force
applying a separation movement, measured as the maxi-
mum tension the material can withstand without integration
failure. Tensiometry results are displayed in Tables 3, 4
and 5. Mean and standard deviation were calculated per
group and one-way ANOVA used to identify differences
between types of matrix. The maximum load sustained by
Table 2 Scoring criteria used for the semi-quantitative histological analysis; units are described per ﬁeld view
Level criterion Absent Marginal Minimal Moderate Complete/severe
01 2 3 4
Integration No integration 1–25% integration 26–50% integration 51–75% integration [75% integration
Cellular density
a No cells (1–30) cells (31–60) cells (61–90) cells [90 cells
Cellular penetration No cells 1–25% penetration 26–50% penetration 51–75% penetration [75% penetration
Neo-vascularisation No vessels (1–5) vessels (6–10) vessels (11–15) vessels [15 vessels
Macrophages and giant
cells











a Non-inﬂammatory host cells
Table 3 Tensiometry results for all treatment groups at 1 month post implantation
A1M SIS1M C1M P1M
N = 6 N = 4 N = 7 N = 6
Maximum load (kg) 0.915 ± 0.194 0.539 ± 0.238 0.235 ± 0.103* 0.730 ± 0.088
Extension at max load (mm) 28.36 ± 10.42 34.32 ± 2.638 29.32 ± 11.91 34.23 ± 9.806
Total extension (mm) 62.55 ± 15.76 64.02 ± 25.58 48.96 ± 18.26 69.81 ± 8.319
* P\0.05
Table 4 Tensiometry results for all treatment groups at 3 months post implantation
A3M SIS3M C3M P3M
N = 6 N = 2 N = 4 N = 6
Maximum load (kg) 0.592 ± 0.266 0.568 ± 0.196 0.476 ± 0.430 0.986 ± 0.215*
Extension at max load (mm) 30.48 ± 15.62 36.46 ± 20.09 17.65 ± 4.554 43.55 ± 8.859
Total extension (mm) 58.50 ± 17.22 80.16 ± 27.56 48.17 ± 2.787 58.79 ± 18.67
* P\0.05 between crosslinked matrices
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123the CollaMend
TM* implants was statistically lower than
with the AlloDerm
* and Permacol
TM implants at 1 month
post implantation. At this time point, no signiﬁcant dif-
ference was observed in the other parameters. At 3 months
post implantation, the extension at maximum load was
signiﬁcantly different between the crosslinked matrices
(C3M and P3M). Most SIS6M implants had been absorbed at
6 months post implantation; therefore, there was no exist-
ing material remaining to test for tensiometry in this group.
Total extension values were signiﬁcantly different for the
AlloDerm
* implants at this time point.
It is important to state that stretching of AlloDerm
*
was observed for all implants.
Histopathology
Sections taken from the collagenous prosthetic biomateri-
als before implantation showed good quality non-denatured
collagen in all biological prostheses tested. Cells or cellular




TM, although nuclear material was
visible in high quantities in SIS (Fig. 1).
Control tissue showed no reactivity to the surgical pro-
cedure at all time points assessed. On examination under
polarised light, a normal, non-denatured collagen pattern-
ing was demonstrated in the controls.
One month
In group A1M, two implants showed signs of severe acute
and chronic inﬂammatory responses (Fig. 2a). AlloDerm
*
was heavily invaded by inﬂammatory cells, but in places
where the inﬂammatory response was absent, the implant
was cell free. In both implants an inﬂammatory response
was observed between the AlloDerm
* and the abdominal
wall. The remaining four implants had moderate levels of
acute and chronic inﬂammatory responses. Lymphocytes,
macrophages and polymorphs were present in all implants
of this group. In three implants neutrophils were acting as a
barrier, surrounding the implant and separating it from the
adjacent tissue. Giant cells and ﬁbrotic activity were
present in four A1M implants. As observed in the Allo-
Derm
* implants, SIS showed evidence of severe acute and
chronic inﬂammatory responses, moderate to severe ser-
oma induction, delamination and severe enlargement and
activation of local lymph nodes (Fig. 2b). Furthermore, SIS
implants were associated with moderate levels of necrosis,
ﬁbrosis and mineralisation. The level of inﬂammation in
the non-crosslinked matrices was signiﬁcantly higher than
in the crosslinked matrices (P\0.001).
At 1 month post implantation, Permacol
TM was associ-
ated with minimal and marginal levels of acute and chronic
inﬂammatory responses, respectively. The animals from
group C1M that were sacriﬁced prematurely due to seroma
development and subsequent open wound formation,
showed minimal acute and chronic inﬂammatory respon-
ses; it is not evident if these responses were a result of the
seroma or of the open wound. As observed in the Allo-
Derm
* implants, neutrophils, macrophages and giant cells
were visible in P1M implants. The C1M animals that reached
the expected end-time point, showed no inﬂammatory
response apart from the presence of low numbers of mac-
rophages. One month post-surgery, the control defects
showed no evidence of an inﬂammatory response; orga-
nized collagen deposition was observed within the hernia
defect. With time, the extracellular matrix observed in the
control tissue became more compact and, at 3 months post
implantation, an organized extracellular matrix was
observed, although herniation was still present. Finally, at
6 months, it was not possible to distinguish between the
healthy tissue and the defect area in the control hernia
defects.
Table 5 Tensiometry results
for all treatment groups at
6 months post implantation
* P\0.05
A6M SIS6M C6M P6M
N = 4 N = 7 N = 6
Maximum load (kg) 0.821 ± 0.494 – 0.833 ± 0.285 1.042 ± 0.310
Extension at max load (mm) 20.02 ± 6.178 – 30.95 ± 18.93 30.56 ± 10.85
Total extension (mm) 29.16 ± 6.95* – 61.29 ± 23.69 54.25 ± 14.68
Fig. 1 Non-implanted Surgisis Gold
TM showing high quantities of
nuclear material. Nuclear material stains purple and collagen stains
pink (H&E, 9200)
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123When cellular density was high, blood vessels were
visible to support cells. In these places AlloDerm
* and SIS
lost their original conﬁguration and were remodelled while
implant cell free areas maintained their original structure.




At the earliest time point, AlloDerm
* lost its natural
birefringence, especially at the edges, which indicates
collagen degradation; such a result was probably a conse-
quence of the high cellular activity caused by the inﬂam-
matory response observed (Fig. 3). This feature was not
observed in the other tested matrices.
Integration with the host tissue was high in group A1M,
especially in the areas where inﬂammatory cells were
predominant. Groups P1M and SIS1M showed minimal
levels of tissue integration but CollaMend
TM* implants did
not show ﬁbres attaching the implant to the host tissue,
except in one aspect where ﬁbrin micro-interdigitations
were observed between the edge of one implant and the
immediately adjacent host tissue.
While the majority of the cells inﬁltrating groups A1M
and SIS1M were leukocytes, ﬁbroblasts were observed in
groups P1M and C1M at minimal and marginal levels. It is
important to note, however, that, in group C1M, ﬁbroblasts
were present mainly in the spaces between collagen ﬁbres
and not within the ﬁbres. Independent of the level of cel-
lular density, cellular penetration reached 100% in all
matrices.
Three months
Most implants from group A3M showed the remains of
marginal to moderate acute and chronic inﬂammatory
response; these responses were signiﬁcantly different from
the values obtained at 1 month post implantation. Because
of the inﬂammatory response, implants were heavily pop-
ulated with cells and AlloDerm
* conﬁguration changed
when a high cellular density was observed. Macrophages
were visible in large numbers, especially at the edges of the
implants; giant cells were also present but in lower num-
bers and mature vessels and vessel sprouts were present to
support the cellular population. Once more, lymphocytes
were visible in excessive numbers indicating a signiﬁcant
immune response. A cellular barrier, constituted mainly by
lymphocytes, was visible surrounding the AlloDerm
*
implants. Despite the lymphocytic barrier, cellular pene-
tration reached 100% in all implants and integration with
the surrounding tissue was graded as ‘‘moderate to com-
plete’’. Implants with a moderate inﬂammatory response
showed collagen degradation demonstrating implant
breakdown.
At 3 months post implantation, SIS implants showed
severe acute and chronic inﬂammatory response and
Fig. 2 a AlloDerm
* implant, 1 month post implantation, showing
severe acute and chronic inﬂammatory responses, with inﬂammatory
cells inﬁltrating the matrix aggressively. b Enlarged lymph node (LN)
in the vicinity of a SIS implant, 1 month post implantation. (H&E,
920)
Fig. 3 Degraded collagen in an AlloDerm
* implant, under polar-
ized light (picro sirius red staining 920)
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123delamination (Fig. 4). There remained moderate amounts
of seroma, necrosis, ﬁbrosis and mineralisation. Conse-
quently, SIS implants were heavily populated by leuko-
cytes; ﬁbroblasts represented only a smaller fraction of the
cell population. There was also continued severe enlarge-
ment and activation of local lymph nodes. In contrast to
what was observed in group A3M, the elevated cellular
density observed did not contribute to increased tissue/
implant integration; tissue integration with the surrounding
host tissue was mild.
Only four animals from group C3M reached the protocol
experimental ﬁnal time-point. The implants retrieved from
the animals sacriﬁced prematurely showed evidence of
bacterial contamination, most probably as a result of the
open wounds. In the presence of bacteria, the Coll-
aMend
TM* matrix was degraded and remodelled. By con-
trast, the four CollaMend
TM* implants recovered at
3 months post implantation showed no evidence of an
inﬂammatory response, and matrix degradation was not
observed. In addition, integration with the adjacent tissue
increased to minimal levels, which was signiﬁcantly dif-
ferent from 1 month post implantation. However, tissue
integration was observed mainly within the implant surface
facing the subcutaneous tissue and not in the defect area
(Fig. 5). Cellular density was minimal and cells were
observed fully penetrating the implant, mainly through
natural ﬁssures. Macrophages and giant cells were present
at the edges of the C3M implants, which is consistent with a
foreign body reaction. Consistent with the number of cells
observed, vessels were observed in the edges and centre of
the implant, although at low levels.
The implants from group P3M showed no evidence of
inﬂammatory or immune responses, which differed
signiﬁcantly (P\0.01) from group P1M. Cellular density
was higher than at 1 month, with complete cellular pene-
tration. Fibroblasts were the main cell type present within
the Permacol
TM implants (Fig. 6). As a result, tissue inte-
gration increased signiﬁcantly (P\0.01), being moderate
to complete at this time point.
Six months
Two implants from group A6M were absorbed; the other
four implants were completely integrated with the sur-
rounding tissue but still identiﬁable. The inﬂammatory and
immune responses observed at earlier times had resolved
and were not observed at 6 months; nevertheless, some
macrophagic activity was present and giant cells were
observed in one implant, suggesting further remodelling of
the matrix. Cellular density increased signiﬁcantly com-
pared to groups A1M and A3M, reaching moderate levels,
and cellular penetration was 100% in all AlloDerm
*
implants. Neo-vascularisation was present to support the
cells. On examination under polarised light, normal, non-
denatured collagen patterning was present. Given that at
the earlier time points collagen degradation was observed,
the normal birefringent collagen patterning observed at
6 months is probably caused by deposition of new colla-
gen, although implants show both mature (thick ﬁbres) and
new (thin ﬁbres) collagen.
Like AlloDerm
*, SIS implants were partially absorbed
and remodelled but, in contrast to AlloDerm
*, group
SIS6M presented levels of acute and chronic inﬂammatory
responses; these parameters differed signiﬁcantly from the
previous time points. Implant delamination was moderate
while seroma, necrosis, ﬁbrosis and mineralisation were
evident but at mild levels. Tissue integration was signiﬁ-
cantly higher compared to the previous SIS groups; after
Fig. 4 Implant from group SIS1M showing evidence of a severe
implant inﬂammatory response (arrowheads), including delamination
of implant (arrows), seroma (asterisks) and tissue necrosis (open head
arrows) (H&E, 920)
Fig. 5 CollaMend
TM* implant, 3 months post implantation, showing
no tissue integration with the hernia defect site (H&E, 920)
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1236 months of implantation, SIS tissue integration with the
host tissue was complete.
Both crosslinked implant types showed good quality
collagen under polarised light; implant remodelling and
degradation were not observed and collagen was naturally
birefringent.
Two animals from group C6M showed a small lump
externally. In the ﬁrst animal CollaMend
TM* was folded at
one edge and a marginal inﬂammatory response was
present in this area. In the second animal, a ﬁbrotic mass
was visible between the implant and the peritoneal wall,
demonstrating a marked tissue response to the implant.
Among the ﬁbrotic tissue, new collagen was forming and
the initial stages of calciﬁcation were observed (Fig. 7).
Calciﬁcation was conﬁrmed with von Kossa’s staining.
Group C6M showed low integration with the surrounding
tissue; in particular the implant surface facing the perito-
neal wall. In some localized areas of the surfaces in contact
with the skin, tissue integration reached moderate levels.
Independent of the level of tissue integration, cellular
density varied from minimal to moderate, and cellular
penetration reached 100% in all implants. To support the
cell population, vessel sprouts and mature vessels were
observed in high numbers both at the edges and in the
centre of the implants. Five implants of group C6M showed
minimal-to-moderate numbers of macrophages and giant
cells. This occurred more often in the middle of the implant
than at the borders. Lymphocytes and plasma cells were
also observed, suggesting an immune response. One
implant showed a localized chronic inﬂammatory response,
with high numbers of lymphocytes, giant cells and mac-
rophages. In this area, cellular density was complete and
integration with surrounding tissue was absent.
Group P6M showed no evidence of inﬂammatory or
immune response. Interestingly, cellular density decreased
to marginal levels, leaving implants almost cell free
(Fig. 8). Independent of the number of cells within the
matrix, integration with host tissue was minimal. Mild
levels of mineralisation were observed in the centre of
three implants, cellular response was not observed in such
areas.
Figure 9 shows the semi-quantitative histometric results
for groups at all time points.
Discussion
Ventral hernia repair remains one of the most common
surgical procedures. However, results from ventral hernia
repair are less than optimal, with recurrence rates of 12.3%
at 5 years and 23% at 13 years [39]. Currently, numerous
Fig. 6 Permacol
TM implant, group P3M, with moderate cellular
density and complete cellular penetration (H&E, 9100)
Fig. 7 Calciﬁed tissue adjacent to a CollaMend
TM* implant
6 months after implantation (H&E, 920)
Fig. 8 Permacol
TM implant, 6 months post-implantation with low
level of cellular density. Cells are observed mainly at the edges of the
implant (arrow) (H&E, 9100)
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123bioprostheses are available in the surgical ﬁeld. Their
potential beneﬁts include a reduced tendency towards
infection compared to synthetic materials, increased bio-
compatibility, and lowered host foreign-body responses.
There are several types of acellular biologic prostheses
used clinically for hernia repair and these are characterised
mainly by their animal source and applied treatments. This
study investigated four commercially available biologic
prostheses recommended by manufacturers as being
effective in abdominal wall hernia repair: AlloDerm
*—a
non-crosslinked human derived mesh, Surgisis Gold
TM—a




porcine derived biological meshes.





SIS showed evidence of nuclear material, which may
explain the severe inﬂammatory and immune responses
observed post-implantation. The non-crosslinked meshes
(AlloDerm
* and SIS) were structurally different from the
crosslinked meshes. The latter showed more organised and
compact collagen ﬁbres with a particular spatial orienta-
tion, strongly contrasting to the interlinked collagen mesh
observed in the non-crosslinked collagen matrices, which
reﬂects the different anatomical locations of the source
material.
Tensiometry results for AlloDerm
* showed high
maximum load values at 1 month post implantation; these
Fig. 9 Histometric results for 1, 3 and 6 months post implantation (mean and SEM)
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difference between the time-points tested. The moderate-
to-severe inﬂammatory response observed may have
affected the tensiometry results at 1 month. The increase in
the maximum load value from 3 to 6 months suggests an
increase in the level of integration, which is corroborated
by the histological analysis. It is important to note that
stretching of AlloDerm
* was observed in all implants
throughout tensiometry analysis. Values for maximum load
sustained by SIS implants were similar at both 1 and
3 months; however, due to implant absorption, at 6 months
there was not enough implant present to perform tensi-
ometry. Remodelling and absorption of non-crosslinked
meshes have been described previously to occur by
4–6 months post implantation [30–32].
Macroscopic observation of CollaMend
TM* samples
during tensiometry testing indicated that integration with
the surrounding tissue was low; these ﬁndings were con-
ﬁrmed later by histopathology analysis. Permacol
TM max-
imum load results differed signiﬁcantly different from
those of CollaMend
TM* at 1 month post implantation but,
although Permacol
TM sustained higher loads at 3 and
6 months compared to all other matrices, this was not
statistically signiﬁcant. Integration of Permacol
TM with the
host tissue increased with time; this result was observed
both with the tensiometry and histopathological analysis.
The physical and mechanical properties of Coll-
aMend
TM* interfered with the study model assessed. The
folding of the implant caused discomfort to the animals and
eventually exposure of the implant. As previously reported,
one animal had to be sacriﬁced as a result of an open
wound caused by friction between the implant and the skin.
This caused a moderate suppurative inﬂammation as a
result of infection by bacteria. The bacteria seemed to have
a remodelling effect within the CollaMend
TM* matrix,
though the collagen was not degraded. This observation
questions the durability of CollaMend
TM*, particularly in
complex environments such as contaminated wounds.
Similar results were obtained from animals that were sac-
riﬁced as a result of seroma development and subsequent
open wounds.
The marketing literature for the devices studied claims
host acceptance and strong repair of soft tissue defects. The
host response in the present study showed that there were
differences in the amount and temporal appearance of
inﬂammatory cells and the morphologic structural integrity
of the meshes over time. AlloDerm
* was associated with
moderate-to-severe suppurative acute and chronic inﬂam-
matory reactions at 1 month post implantation, consisting
of an exudate rich in polymorphonucleocytes (PMNs) and
lower numbers of mononucleocytes. Fibrotic activity was
also observed at this time point, with a high concentration
of ﬁbrin surrounding the implants. Inﬂammation
diminished over the study period and was completely
resolved at 6 months. The PMN inﬁltration was resolved at
3 months but macrophages and giant cell numbers were
maintained, decreasing at 6 months. These results are in
accordance with a study performed by Gaertner and co-
workers [9] where they tested AlloDerm
* for ventral
hernia repair and reported minimal inﬂammation up to
3 months post implantation. SIS showed the most severe
and long lasting inﬂammatory and immune responses. In
addition, implant delamination¸ necrosis, ﬁbrosis and
mineralisation were also observed at all time points.
Another worrying feature observed with SIS implants was
the induction of seroma to the point of necessary termi-
nation of some of the study subjects; this was matched only
by the CollaMend
TM* groups, where animals with seroma
chewed through the skin. However, in contrast to the SIS
implants, CollaMend
TM* showed no evidence of inﬂam-
mation in the implants that reached their planned sacriﬁce
date. Similarly, the level of inﬂammation observed in the
Permacol
TM group at 1 month was low and completely
resolved by 3 months.
The most concerning clinical feature observed was the
enlargement and activation of lymph nodes in both the
AlloDerm
* and SIS implants. This indicates a signiﬁcant
host immune response to the implant. Such an effect can
pose a problem, especially in challenging clinical ﬁelds
such as contaminated wounds. Biological meshes should
not induce intense inﬂammatory reactions as this may
impair the function of local host tissue defences by
reducing leukocyte ability to opsonise and phagocytise
bacteria.
Cellular density was high at 1 month in the non-cross-




showed minimal numbers of ﬁbroblasts invading the
implants at this time point. Cellular density increased for
all matrices at 3 months and for CollaMend
TM* and SIS at
6 months. The reduction in cellular presence between 3 and
6 months observed in AlloDerm
* and Permacol
TM was
intriguing. Although at 6 months both matrices showed a
decrease in cellular inﬁltration (slight in the case of Allo-
Derm
* and pronounced in Permacol
TM), tissue integration
with the immediately adjacent host tissue was maintained.
These results imply that a constant high number of cells is
not necessary for good implant/tissue integration. Cellular
ingrowth failure in Permacol
TM implants has been reported
by other authors [33, 34], and crosslinking was suggested
as one of the causes for the paucity of cellular penetration
and cellular density. However, in this study, independent of
the number of cells present, cells penetrated through the
full depth of the implant, in all implant types, at both 3 and
6 months. This result is in contrast to that obtained in a
study performed by Eberli and colleagues, where they
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model [35]. They reported that, regardless of a rapid
inﬁltration of host cells from the edges of the implant, the
central regions of AlloDerm
* remained free of cells for
more than 3 months; this difference in results suggests that
the cellular response to AlloDerm
* may be species-spe-
ciﬁc or variable due to product variability.
A review of the literature revealed contradictory out-
comes when using AlloDerm
* for abdominal wall recon-
struction. While some authors reported no complications,
others reported a wide range of mesh-associated problems.
Buinewicz and Rosen [17] used AlloDerm
* to repair
ventral hernias in 44 patients (mean follow-up 20 months),
8 of whom had previous wound infections, and reported no
complications or postoperative wound infections. Patton
and colleagues [18] performed abdominal wall reconstruc-
tion with AlloDerm
* in 67 patients, with an average follow
up of 10.6 months, and reported 18% recurrent hernias (12
patients), 11 patients had wound infection, 2 patients nee-
ded mesh removal, 3 patients developed seroma and 3
patients developed ﬁstulas. Similarly, Gupta and colleagues
reported a clinical study with 33 patients using AlloDerm
*
to repair ventral hernias, with a follow up of 18 months;
they observed 24% of hernia recurrence, 6% seroma
development and 45% of diastasis or bulging of muscle
[21]. In the same study, Surgisis Gold
TM was used in 41
patients, and there were no hernia recurrences with a mean
follow-up of approximately 29 months [21]. Interestingly,
when using non-perforated Surgisis mesh, the authors
reported signiﬁcant seroma formation (91% patients). Ser-
oma complications were not eliminated with the use of
perforated Surgisis but were reduced (23%). Eight of the
patients with seroma had their wound re-explored, and of
these, ﬁve had their mesh explanted. In all of these, the
hernia repair was found intact and there were no hernia
recurrence. In contrast, Helton and colleagues reviewed 53
patients in whom Surgisis Gold
TM was used in abdominal
wall surgery, and reported hernia recurrence (17%), mesh or
wound infection (11%), partial dehiscence of the wound
(21%), with a total of 22 patients (41%) sustaining one or
more postoperative complication [6].
To the authors’ best knowledge there is only one pub-
lished account of the performance of CollaMend
TM*i n
humans. Chavarriaga et al. [28] reported a study where 18
patients underwent abdominal wall reconstruction with
CollaMend
TM*; they reported a recurrence rate of 44.4%.
In addition, a total of approximately 39% of patients
developed post operative wounds complications, including
infection. Patients with infection had to have the prostheses
removed due to encapsulation of the implant rather than
incorporation. In our in vivo study, integration in the
CollaMend
TM* groups was always greater on the side
implanted facing the skin, whereas the CollaMend
TM* side
opposed to the peritoneal wall had low integration. This
result questions the efﬁciency of CollaMend
TM* when used
as a hernia repair biomaterial, since lack of integration with
muscle decreases the healing rate and does not provide
tissue support for hernia healing. Poor tissue integration
and the adverse tissue reactions observed may explain, in
part, post operative wound complications.
Like AlloDerm
*, Permacol
TM surgical implant has
been occasionally associated with post-surgery complica-
tions when used in abdominal wall reconstruction but in
other cases surgeons reported uneventful recoveries. When
faced with complicated incisional hernias with contami-
nation, Catena and co-workers [36] used Permacol
TM for
hernia repair in seven patients and reported no recurrence
or wound infection post surgery; the mean follow up was
11 months. Shaikh and colleagues [37] used Permacol
TM in
8 patients for reconstruction of acute abdominal wall
defects and in 12 patients with chronic abdominal wall
defects; 16% had an uneventful recovery while 2 patients
developed seroma, there were 3 hernia recurrences, 2
patients developed wound infection, 1 patient had a wound
hematoma, 1 patient had a wound dehiscence and 1 patient
developed a wound sinus.
A marked difference between the morphologic structural
integrity of the analysed prosthetic materials was observed.
Macrophages and multinucleated giant cells were present in
higher numbers following an inﬂammatory response in the
AlloDerm
* groups and at lower numbers in the other
matrices. Whilst AlloDerm
* and SIS collagenous matrices
showed degradation, at 1 and 3 months, respectively, the
crosslinked prostheses did not, except for very low levels of
collagen degradation in group C6M when a localized chronic
inﬂammatoryresponsewaspresent.Thisresponsewasrelated
to the presence of giant cells but the remaining areas of the
implant were not degraded or remodelled. The opposite was
observed in AlloDerm
* and SIS implants. When inﬂam-
matory cells were present, the non-crosslinked matrices were
remodelled, losing their initial structure and assuming a
conﬁguration where ﬁbres were orientated spatially. Also,
AlloDerm
* implant presence decreased with time, and
matrix absorption was even more evident in SIS implants.
Although AlloDerm
* and SIS were degraded at earlier
stages of implantation; neo-collagenesis occurred and new
collagen was produced to replace the implant. In contrast,
CollaMend
TM* and Permacol
TM were not remodelled and,
during the period of this study, matrix absorption was not
reported. Such a difference is most likely a result of cross-
linking, which should increase the material’s resistance to
proteolytic activity and explain the durability of these mate-
rials in long-term studies. However, in the Permacol
TM
groups,implantintegrationwiththesurroundingtissuewasof
good quality and strength, indicating that rapid matrix
resorptionisnotaprerequisiteforherniarepairwithbiologics.
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some Permacol
TM implants at 6 months, and calciﬁcation,
which was associated with ﬁbrosis, was observed in one
CollaMend
TM* implant, also at 6 months. In the latter,
integration with the host tissue was low and may be
explained by the ﬁbrotic mass found between the implant
and the peritoneal wall, which decreased the contact area
between the implant and the adjacent tissue. Permacol
TM
mineralisation has been reported before by Kelley and
colleagues [38], who reported dystrophic calciﬁcation and
bone formation in Permacol
TM implants at 12 months post
subcutaneous implantation in mice. Crosslinking was sug-
gested as the cause of the presence of mineralisation. This
study suggests otherwise, since SIS implants, a non-
crosslinked matrix, showed mineralisation as early as
1 month post implantation, and this feature was observed
throughout the study. Although the cause of implant min-
eralisation is still unknown, based on our results, we sug-
gest that crosslinking is not the factor, or at least is not the
only factor, contributing to implant mineralisation. Further
studies are needed to explain why mineralisation occurs
and the time-frames of such episodes. It is important to
note that the presence of mineralised matrix did not appear
to be detrimental to the performance of Permacol
TM;
integration with the host tissue was at the same level as
observed in non-mineralised Permacol
TM matrices at the
same time-point. Moreover, no inﬂammatory or immune
response was evident in these implants.
The control defects showed a very good rate of healing
throughout the study. The control tissue observed 1 month
post implantation showed herniation but with good rate of
neocollagenesis and tissue reconstruction was already visi-
ble. This was further accentuated at 3 months, where the
ECM was structurally organised. Finally, at 6 months post




activity, which probably helped the healing of the hernia.
Regarding technical limitations, the chosen model does
not consider the risk of adhesion formation. This is an
important parameter when evaluating the use of meshes in
hernia repair and further studies should comprise full per-
itoneal defects for a more complete assessment and com-
parison of bioprostheses performance in abdominal wall
repair.
Conclusion
Experimental investigations in biologic prosthetic materi-
als are important as adverse effects and unfavourable
properties of these materials have been demonstrated in
laboratory trials. Some of the complications that have
occurred clinically may be due to the use of unsuitable
materials.
In the rodent model reported here AlloDerm
* and
Surgisis Gold
TM showed tissue reactivity with the host;
therefore, caution is advised when using these matrices for
tissue reconstruction in critically ill patients. Furthermore,
the rapid rate of remodelling and degradation of the non-
crosslinked matrices may bring further problems in the
clinical setting when the overall quality and strength of the
newly formed tissue is insufﬁcient for abdominal wall
repair, especially where bacterial contamination, which
will increase tissue degradation, is suspected. Nevertheless,
subjects implanted with non-crosslinked matrices that
overcome the initial complications, and reached 6 months
post implantation, showed a healed hernia. In the study
reported here, due to its physical and biological properties,
CollaMend
TM* Implant proved to be unsuitable for hernia
repair under the conditions tested. Permacol
TM biological
implant integration with the host tissue increased over
time, supporting hernia healing with sufﬁcient strength of
tissue. It appears to be a safe prosthetic material for ventral
hernia repair based on the results of this rodent study.
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